Negotiated pharmaceutical sales driven by medical insurance
Cumulative sales volume or value of negotiated pharmaceutical products driven by strategic purchasing from medical insurance funds.
Unit billion CNY Industry Pharmaceuticals
The chart
The figure
One published observation so far. A chart follows as soon as a second period is published.
Negotiated pharmaceutical sales driven by medical insurance
China, as of 28 Feb 2026
Every record
All records
1 record · 1 region · 2018–2026
| Period | Value | Source | Type |
|---|---|---|---|
| China 1 record | |||
| as of 28 Feb 2026 | 740 billion CNY | NHSA · 28 Feb 2026 | actual |
Primary documents
Sources
1 document. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| 国家医疗保障局 医保动态 国新办举行国务院政策例行吹风会介绍健全全周期全渠道药品价格形成机制有关情况 | NHSA | — | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Negotiated pharmaceutical sales driven by medical insurance. Retrieved from https://statorigin.org/indicators/negotiated-pharmaceutical-sales-driven-by-medical-insurance